Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma.

Milan JovanovicNevena GajovicNatasa ZdravkovicMarina JovanovicMilena JurisevicDanilo VojvodicVeljko MaricAleksandar ArsenijevicIvan P Jovanovic

Published in: Mediators of inflammation (2018)

Predomination of Gal-3 in patients with advanced diseases may implicate on its role in limiting ongoing proinflammatory processes. The fecal values of Gal-3 can be used as a valuable marker for CRC severity and progression.

Keyphrases